Key facts
- This page summarizes Arjun Jj Desai's Form 4 filing for Clene Inc. (CLNN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 14 Aug 2026, 15:32.
Arjun Jj Desai - 13 Aug 2026 Form 4 Insider Report for Clene Inc. (CLNN)
- Reporting relationship
- Director
- Issuer ticker
- CLNN
- Reported as of
- 13 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Aug 2026, 15:32:05 UTC
- Prior SEC filing
- 14 Jul 2026
- Next SEC filing
- 21 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jerome T. Miraglia POA
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Arjun Jj Desai filed Form 4 for Clene Inc. (CLNN) on 14 Aug 2026.
Change
- Previous filing in this sequence was filed on 14 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001982985
Primary reporting owner
Desai Arjun JJ
- Relationship
- Director
- Address
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
- Signature
- /s/ Jerome T. Miraglia POA
- Signature date
- 14 Aug 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CLNN
transaction
Derivative
stock option
Award
- Transaction value
- Shares
- +3,674
- Change %
- Price
- $0.000000*
- Shares after
- 3,674
- Date
- 13 Aug 2026
- Ownership
- Direct
- Underlying class
- common stock
- Underlying amount
- 3,674
- Exercise price
- $4.19
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This option was granted on August 13, 2026 as an option for 3,674 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.